Current Report Filing (8-k)
December 22 2016 - 7:51AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE
ACT OF 1934
Date of report (Date of
earliest event reported): December 8, 2016
ALBANY MOLECULAR RESEARCH,
INC.
(Exact name of registrant
as specified in its charter)
Delaware
(State or other jurisdiction
of incorporation)
001-35622
|
14-1742717
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
26 Corporate Circle
Albany, New York
|
12212
|
(Address of principal executive offices)
|
(Zip
Code)
|
(518) 512-2000
(Registrant’s telephone
number, including area code)
(Former address, if changed
since last report)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
|
¨
|
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01 Other Events.
Sodium Nitroprusside Injection, one of the Company’s
products developed pursuant to a drug product co-development agreement with a partner, was launched, following the approval of
such product by the FDA on December 8, 2016.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
ALBANY MOLECULAR RESEARCH, INC.
|
|
|
|
|
|
|
|
By:
|
/s/ Lori M. Henderson
|
|
|
|
Lori M. Henderson
Senior Vice President, General Counsel & Secretary
|
|
|
|
|
|
Date:
|
December 22, 2016
|
|
Albany Molecular Research, Inc. (NASDAQ:AMRI)
Historical Stock Chart
From Apr 2024 to May 2024
Albany Molecular Research, Inc. (NASDAQ:AMRI)
Historical Stock Chart
From May 2023 to May 2024